![](../../files/images/goods/224789-15-5.png)
Vardenafil Dihydrochloride Salt
CAS No. 224789-15-5
Vardenafil Dihydrochloride Salt ( BAY38-9456 | Vardenafil HCl | Levitra | Staxyn | Vivanza )
产品货号. M13612 CAS No. 224789-15-5
Vardenafil DiHClide Salt 是一种磷酸二酯酶抑制剂,对 PDE5 和 PDE1 具有选择性(IC50 分别为 0.7 和 180 nM)。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
25MG | ¥373 | 有现货 |
![]() ![]() |
50MG | ¥680 | 有现货 |
![]() ![]() |
100MG | ¥1239 | 有现货 |
![]() ![]() |
200MG | ¥2187 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Vardenafil Dihydrochloride Salt
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Vardenafil DiHClide Salt 是一种磷酸二酯酶抑制剂,对 PDE5 和 PDE1 具有选择性(IC50 分别为 0.7 和 180 nM)。
-
产品描述Vardenafil Dihydrochloride Salt is a phosphodiesterase inhibitor that is selective for PDE5 and PDE1 (IC50 = 0.7 and 180 nM, respectively).
-
体外实验Vardenafil dihydrochloride specifically inhibits the hydrolysis of cGMP by PDE5 with an IC50 value of 0.7 nM.Vardenafil dihydrochloride increases intracellular cGMP levels in the cavernosum tissue of the penis, thus results increasing the dilation of the body's sinuses and blood flow.
-
体内实验Vardenafil dihydrochloride (0.03 mg/kg; i.v.) exhibits facilitator effects in rats with cavernous nerve injury.Vardenafil dihydrochloride (0.17 mg/kg; i.v.; once daily; 7 d) protects liver against Con A–induced hepatitis, and decreases the expression of NF-??B and iNOS in hepatic tissue.Vardenafil dihydrochloride (10 mg/kg; p.o.; once daily; 25 weeks) prevents the reduction of tissue cGMP levels and the increase in 3-NT generation in ZDF hearts. Animal Model:Male rat (9-week-old) underwent surgery for laparotomy or bilateral cavernous nerve (CN) crush injury Dosage:0.03 mg/kg Administration:Intravenous injection Result:Restored normal erectile responses with a combind administration of BAY 60-4552 (0.03, 0.3 mg/kg).Animal Model:Liver injury induced by Con A in male Swiss albino mice (20 ± 2 g)Dosage:0.17 mg/kg Administration:Intravenous injection; once daily, for 7 days; as a pretreatment Result:Reduced the levels of serum transaminases and alleviated Con A-induced hepatitis.Animal Model:Male 7-week-old Zucker diabetic fatty (ZDF) rats (preserved ejection fraction, HFpEF)Dosage:10 mg/kg Administration:Oral gavage; once daily, for 25 weeks Result:Improved myofilament function in diabetic rat hearts.
-
同义词BAY38-9456 | Vardenafil HCl | Levitra | Staxyn | Vivanza
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number224789-15-5
-
分子量680
-
分子式C29H40N6O11S
-
纯度>98% (HPLC)
-
溶解度N/A
-
SMILESO=C1N=C(C2=CC(S(=O)(N3CCN(CC)CC3)=O)=CC=C2OCC)NN4C1=C(C)N=C4CCC.[H]Cl.[H]Cl
-
化学全称2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one dihydrochloride
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Bischoff, E., et al.: J. Urol., 165, 1316 (2001) Kim, N.N., et al.: Life Sci., 69, 2249 (2001) Kendirci, M., et al.: Expert Opin. Pharmacother., 5, 923 (2004)